{"type":"rich","html":"<script src=\"http:\/\/leconomic.cat\/media\/epa\/iframeresizer\/iframeResizer.min.js\"><\/script><iframe class=\"epa-embed\" src=\"http:\/\/leconomic.cat\/article\/1532626-biotecnologia-per-al-2019.html?utm_medium=oembed&amp;utm_source=desconegut&amp;utm_campaign=oembed&amp;layout=oembed&amp;tmpl=oembed\" height=\"auto\" frameborder=\"0\" style=\"border: 0px; margin: 1px; min-height: 200px;  max-width: 658px; width: calc(100% - 2px); display: block; padding: 0px; background: rgb(255, 255, 255);\"><\/iframe><script>iFrameResize({log:false, checkOrigin: ['http:\/\/leconomic.cat']})<\/script>","version":"1.0","provider_name":"El Punt Avui","provider_url":"http:\/\/www.elpuntavui.cat","resource_url":"http:\/\/leconomic.cat\/article\/1532626-biotecnologia-per-al-2019.html?utm_medium=oembed&amp;utm_source=desconegut&amp;utm_campaign=oembed","title":"Biotecnologia per al 2019","description":"L\u2019any que acabem de comen\u00e7ar, ser\u00e0 decisiu en molts \u00e0mbits i tamb\u00e9 ho ser\u00e0 per al sector biotech de Catalunya. Al m\u00e9s de maig, Barcelona acollir\u00e0 la confer\u00e8ncia BioEquity Europe, una de les cites...","author_name":"Maribel Berges","author_url":"http:\/\/leconomic.cat\/e-opinio\/autor\/mberges.html?app_id=102","thumbnail_url":"https:\/\/www.elpuntavui.cat\/imatges\/58\/05\/baixa\/780_0008_5805121_90e216f23df3350627a25101a85a51cb.jpg","thumbnail_width":"225","thumbnail_height":"150","width":"100","height":"100"}